Format

Send to

Choose Destination
Anticancer Drugs. 2012 Sep;23(8):777-87. doi: 10.1097/CAD.0b013e3283541384.

Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.

Author information

1
State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, China. xpchen@umac.mo

Abstract

Cucurbitacin and its derivatives (cucurbitacins) are a class of highly oxidized tetracyclic triterpenoids. They are widely distributed in the plant kingdom, where they act as heterologous chemical pheromones that protect plants from external biological insults. Their bioactivities first attracted attention in the 1960s. Documented data demonstrate that cucurbitacins possess strong pharmacological properties, such as antitumor, anti-inflammatory, and hepatoprotective effects, etc. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription 3, cyclooxygenase-2, etc. The present study summarizes the achievements of the 50 years of research on cucurbitacins. The aim was to systematically analyze their bioactivities with an emphasis on their anticancer effects. Research and development has shed new insight into the beneficial properties of these compounds.

PMID:
22561419
DOI:
10.1097/CAD.0b013e3283541384
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center